BSX
Price
$106.17
Change
+$0.96 (+0.91%)
Updated
Aug 22 closing price
Capitalization
157.32B
58 days until earnings call
NMTC
Price
$0.78
Change
+$0.01 (+1.30%)
Updated
Aug 22 closing price
Capitalization
39.23M
107 days until earnings call
Interact to see
Advertisement

BSX vs NMTC

Header iconBSX vs NMTC Comparison
Open Charts BSX vs NMTCBanner chart's image
Boston Scientific
Price$106.17
Change+$0.96 (+0.91%)
Volume$9.4M
Capitalization157.32B
NeuroOne Medical Technologies
Price$0.78
Change+$0.01 (+1.30%)
Volume$138.88K
Capitalization39.23M
BSX vs NMTC Comparison Chart in %
Loading...
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BSX vs. NMTC commentary
Aug 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Buy and NMTC is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 25, 2025
Stock price -- (BSX: $106.17 vs. NMTC: $0.78)
Brand notoriety: BSX: Notable vs. NMTC: Not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: BSX: 131% vs. NMTC: 54%
Market capitalization -- BSX: $157.32B vs. NMTC: $39.23M
BSX [@Medical/Nursing Services] is valued at $157.32B. NMTC’s [@Medical/Nursing Services] market capitalization is $39.23M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $230.77B to $0. The average market capitalization across the [@Medical/Nursing Services] industry is $5.71B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BSX’s FA Score shows that 1 FA rating(s) are green whileNMTC’s FA Score has 0 green FA rating(s).

  • BSX’s FA Score: 1 green, 4 red.
  • NMTC’s FA Score: 0 green, 5 red.
According to our system of comparison, BSX is a better buy in the long-term than NMTC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BSX’s TA Score shows that 5 TA indicator(s) are bullish while NMTC’s TA Score has 5 bullish TA indicator(s).

  • BSX’s TA Score: 5 bullish, 4 bearish.
  • NMTC’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BSX is a better buy in the short-term than NMTC.

Price Growth

BSX (@Medical/Nursing Services) experienced а +2.91% price change this week, while NMTC (@Medical/Nursing Services) price change was -4.29% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.60%. For the same industry, the average monthly price growth was +1.52%, and the average quarterly price growth was +6.50%.

Reported Earning Dates

BSX is expected to report earnings on Oct 22, 2025.

NMTC is expected to report earnings on Dec 10, 2025.

Industries' Descriptions

@Medical/Nursing Services (+2.60% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BSX($157B) has a higher market cap than NMTC($39.2M). BSX YTD gains are higher at: 18.865 vs. NMTC (-5.001). BSX has higher annual earnings (EBITDA): 4.65B vs. NMTC (-4.51M). BSX has more cash in the bank: 534M vs. NMTC (8.04M). NMTC has less debt than BSX: NMTC (296K) vs BSX (12B). BSX has higher revenues than NMTC: BSX (18.5B) vs NMTC (6.63M).
BSXNMTCBSX / NMTC
Capitalization157B39.2M400,510%
EBITDA4.65B-4.51M-102,965%
Gain YTD18.865-5.001-377%
P/E Ratio63.20N/A-
Revenue18.5B6.63M279,077%
Total Cash534M8.04M6,642%
Total Debt12B296K4,054,054%
FUNDAMENTALS RATINGS
BSX vs NMTC: Fundamental Ratings
BSX
NMTC
OUTLOOK RATING
1..100
8087
VALUATION
overvalued / fair valued / undervalued
1..100
83
Overvalued
42
Fair valued
PROFIT vs RISK RATING
1..100
4100
SMR RATING
1..100
6499
PRICE GROWTH RATING
1..100
5262
P/E GROWTH RATING
1..100
55100
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NMTC's Valuation (42) in the null industry is somewhat better than the same rating for BSX (83) in the Medical Specialties industry. This means that NMTC’s stock grew somewhat faster than BSX’s over the last 12 months.

BSX's Profit vs Risk Rating (4) in the Medical Specialties industry is significantly better than the same rating for NMTC (100) in the null industry. This means that BSX’s stock grew significantly faster than NMTC’s over the last 12 months.

BSX's SMR Rating (64) in the Medical Specialties industry is somewhat better than the same rating for NMTC (99) in the null industry. This means that BSX’s stock grew somewhat faster than NMTC’s over the last 12 months.

BSX's Price Growth Rating (52) in the Medical Specialties industry is in the same range as NMTC (62) in the null industry. This means that BSX’s stock grew similarly to NMTC’s over the last 12 months.

BSX's P/E Growth Rating (55) in the Medical Specialties industry is somewhat better than the same rating for NMTC (100) in the null industry. This means that BSX’s stock grew somewhat faster than NMTC’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BSXNMTC
RSI
ODDS (%)
N/A
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
49%
Bullish Trend 3 days ago
88%
Momentum
ODDS (%)
Bullish Trend 3 days ago
59%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
55%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
58%
Bearish Trend 3 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
45%
Bearish Trend 3 days ago
90%
Advances
ODDS (%)
Bullish Trend 5 days ago
62%
Bullish Trend 3 days ago
87%
Declines
ODDS (%)
Bearish Trend 7 days ago
46%
Bearish Trend 5 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
50%
Bearish Trend 7 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
61%
Bullish Trend 3 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
BSX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NMTC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
SPEU50.110.81
+1.64%
SPDR® Portfolio Europe ETF
XCCC38.920.38
+0.99%
BondBloxx CCC Rated USD HY Corp Bd ETF
BUFY21.590.14
+0.67%
FT Vest Laddered Intl Mod Buffr ETF
APRJ24.860.05
+0.21%
Innovator Premium Income 30 Bar ETF -Apr
MINT100.590.03
+0.03%
PIMCO Enhanced Short Maturity Active ETF

BSX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BSX
1D Price
Change %
BSX100%
+0.91%
ISRG - BSX
71%
Closely correlated
+1.34%
SYK - BSX
67%
Closely correlated
+2.44%
MMSI - BSX
56%
Loosely correlated
+3.26%
ALC - BSX
49%
Loosely correlated
+3.59%
EW - BSX
49%
Loosely correlated
+0.83%
More

NMTC and

Correlation & Price change

A.I.dvisor tells us that NMTC and BSX have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that NMTC and BSX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NMTC
1D Price
Change %
NMTC100%
+1.99%
BSX - NMTC
29%
Poorly correlated
+0.91%
OWLT - NMTC
27%
Poorly correlated
+0.40%
EKSO - NMTC
27%
Poorly correlated
+5.97%
AZTA - NMTC
26%
Poorly correlated
+5.73%
IQV - NMTC
23%
Poorly correlated
+3.11%
More